MIKA ZEERYP: Open Payments
NPI 1952067662 · CLINTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,767 in 87 payments from 22 companies in 2025. Trend: 2023 $1,032 · 2024 $1,042 · 2025 $1,767
Food & beverage: $1,683Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $450 |
| ABBVIE INC. | 27 | $406 |
| GENZYME CORPORATION | 6 | $155 |
| Ardelyx, Inc. | 5 | $95 |
| QOL Medical, LLC | 5 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $81 |
| Novo Nordisk Inc | 3 | $75 |
| Madrigal Pharmaceuticals | 2 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 5 | $41 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, IBSRELA, Sucraid, XIFAXAN, MAVYRET, CREON.
Industry payments across IA — which companies pay providers there.
